4//SEC Filing
Cyclacel Pharmaceuticals, Inc. 4
Accession 0001571049-15-001303
$BGMSCIK 0001130166operating
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 5:09 PM ET
Size
5.7 KB
Accession
0001571049-15-001303
Insider Transaction Report
Form 4
McBarron Paul
DirectorEVP, Finance, CFO, COO
Transactions
- Award
Option
2015-02-18+53,095→ 53,095 totalExercise: $0.86Exp: 2025-02-18→ Common Stock (53,095 underlying)
Footnotes (2)
- [F1]These securities are exercisable over a three-year period, with 1/36 of the options granted vesting on a monthly basis.
- [F2]These securities were granted to Mr. McBarron under the Issuer's Amended and Restated 2006 Equity Incentive Plan as part of the Issuer's annual equity compensation to executive officers.
Documents
Issuer
Cyclacel Pharmaceuticals, Inc.
CIK 0001130166
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001130166
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 5:09 PM ET
- Size
- 5.7 KB